Alyeska Investment Group, L.P. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $4.36 Million - $7.66 Million	-52,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $930,616 - $1.21 Million	-8,454 Reduced 13.87%	52,500 $6.23 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $1,977 - $2,778	20 Added 0.03%	60,954 $8.47 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $418,120 - $589,932	10,233 Added 20.18%	60,934 $3.32 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $5.4 Million - $7.15 Million	-144,545 Reduced 74.03%	50,701 $2.12 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $7.77 Million - $13.1 Million	195,246 New	195,246 $0

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.